A worldwide Phase III trial treating AML with pracinostat

Pracinostat has been shown to be an effective therapy for treating myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML) in several Phase I and Phase II studies. Here, Guillermo Garcia-Mane... Author: VJHemOnc Added: 07/05/2018
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts